Chemical Modification of siRNAs for In Vivo Use

被引:353
作者
Behlke, Mark A. [1 ]
机构
[1] Integrated DNA Technol Inc, Coralville, IA 52241 USA
关键词
D O I
10.1089/oli.2008.0164
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Well over a hundred reports have been published describing use of synthetic small-interfering RNAs (siRNAs) in animals. The majority of these reports employed unmodified RNA duplexes. While unmodified RNA is the natural effector molecule of RNA interference, certain problems arise with experimental or therapeutic use of RNA duplexes in vivo, some of which can be improved or solved through use of chemical modifications. Judicious use of chemical modifications can improve the nuclease stability of an RNA duplex, decrease the likelihood of triggering an innate immune response, lower the incidence of off-target effects (OTEs), and improve pharmacodynamics. This review will examine studies that document the utility of various chemical modifications for use in siRNAs, both in vitro and in vivo, with close attention given to reports demonstrating actual performance in animal model systems.
引用
收藏
页码:305 / 319
页数:15
相关论文
共 154 条
  • [1] Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
    Alexopoulou, L
    Holt, AC
    Medzhitov, R
    Flavell, RA
    [J]. NATURE, 2001, 413 (6857) : 732 - 738
  • [2] Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA
    Allerson, CR
    Sioufi, N
    Jarres, R
    Prakash, TP
    Naik, N
    Berdeja, A
    Wanders, L
    Griffey, RH
    Swayze, EE
    Bhat, B
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (04) : 901 - 904
  • [3] Tolerance for mutations and chemical modifications in a siRNA
    Amarzguioui, M
    Holen, T
    Babaie, E
    Prydz, H
    [J]. NUCLEIC ACIDS RESEARCH, 2003, 31 (02) : 589 - 595
  • [4] Experimental validation of the importance of seed complement frequency to siRNA specificity
    Anderson, Emily M.
    Birmingham, Amanda
    Baskerville, Scott
    Reynolds, Angela
    Maksimova, Elena
    Leake, Devin
    Fedorov, Yuriy
    Karpilow, Jon
    Khvorova, Anastasia
    [J]. RNA, 2008, 14 (05) : 853 - 861
  • [5] Armant MA, 2002, GENOME BIOL, V3
  • [6] Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation
    Bagga, S
    Bracht, J
    Hunter, S
    Massirer, K
    Holtz, J
    Eachus, R
    Pasquinelli, AE
    [J]. CELL, 2005, 122 (04) : 553 - 563
  • [7] Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles
    Bartlett, Derek W.
    Davis, Mark E.
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2008, 99 (04) : 975 - 985
  • [8] Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging
    Bartlett, Derek W.
    Su, Helen
    Hildebrandt, Isabel J.
    Weber, Wolfgang A.
    Davis, Mark E.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (39) : 15549 - 15554
  • [9] Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing
    Bartlett, Derek W.
    Davis, Mark E.
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2007, 97 (04) : 909 - 921
  • [10] Progress towards in vivo use of siRNAs
    Behlke, MA
    [J]. MOLECULAR THERAPY, 2006, 13 (04) : 644 - 670